Spyre Therapeutics Inc (NAS:SYRE)
$ 35.92 0.79 (2.25%) Market Cap: 1.83 Bil Enterprise Value: 1.63 Bil PE Ratio: 0 PB Ratio: 8.35 GF Score: 51/100

Aeglea Bio Therapeutics Inc KOL and Patient Caregiver Webinar on Arginase 1 Deficiency - Corporate Call Transcript

Feb 03, 2022 / 07:30PM GMT
Release Date Price: $104.75 (-1.87%)
Operator

Good afternoon, and welcome to the Aeglea BioTherapeutics KOL & Patient Caregiver Webinar on Arginase 1 Deficiency. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the Aeglea website following the conclusion of the event.

I'd now like to turn the call over to your host, Anthony Quinn, President and Chief Executive Officer of Aeglea BioTherapeutics. Please go ahead, Anthony.

Anthony G. Quinn
Aeglea BioTherapeutics, Inc. - President, CEO & Director

Yes. Thank you for joining us this afternoon for our KOL & Patient Caregiver Webinar on Arginase 1 Deficiency. I'm very excited about the speakers we have for you today who are experts in this rare disease as they are the ones that treat and live with arginase 1 deficiency.

Next slide. Please note that this webinar may include forward-looking statements under the Private Securities Litigation Reform Act. Actual results might differ materially from those projected in the forward-looking statements. Additional information

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot